Morgan Jess S & CO Inc Axsome Therapeutics, Inc. Transaction History
Morgan Jess S & CO Inc
- $115 Million
- Q3 2022
A detailed history of Morgan Jess S & CO Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Morgan Jess S & CO Inc holds 78,895 shares of AXSM stock, worth $7.11 Million. This represents 3.06% of its overall portfolio holdings.
Number of Shares
78,895
Previous 104,889
24.78%
Holding current value
$7.11 Million
Previous $4.02 Million
12.37%
% of portfolio
3.06%
Previous 4.17%
Shares
12 transactions
Others Institutions Holding AXSM
# of Institutions
289Shares Held
40.4MCall Options Held
365KPut Options Held
428K-
Rtw Investments, LP New York, NY4.63MShares$418 Million6.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$337 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$297 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$213 Million37.71% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.85MShares$167 Million4.89% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.86B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...